NCT07413952 2026-02-17
Limertinib Plus Radiotherapy for EGFR-Mutant NSCLC With Brain Metastases
The First Affiliated Hospital of Guangzhou Medical University
Phase 2 Not yet recruiting
Clinical Trials
18 trialsNCT07376382 2026-02-02
SYNSTAR-02
CSPC Megalith Biopharmaceutical Co.,Ltd.
Phase 3 Not yet recruiting
NCT07379398 2026-01-30
Iparomlimab and Tuvonralimab Injection Combined With SBRT in Patients With Early-Stage Non-Small Cell Lung Cancer
Tianjin Medical University Cancer Institute and Hospital
Phase 2 Not yet recruiting
NCT07358689 2026-01-22
Toripalimab Combined With Platinum-based Chemotherapy With or Without H1 Receptor Antagonist in the Perioperative Treatment of Resectable Non-small Cell Lung Cancer
Tianjin Medical University Cancer Institute and Hospital
Phase 2 Not yet recruiting
NCT07281209 2025-12-15
A Study of SHR-A1811 Combined With Adebelimumab as Neoadjuvant Therapy for Resectable HER2-Altered Non-Small Cell Lung Cancer
Shanghai Chest Hospital
Phase 2 Not yet recruiting
NCT07179445 2025-09-17
Analysis of Deoxyribonucleic Acid and Ribonucleic Acid Next-Generation Sequencing in Non-Small Cell Lung Cancer Patients Without Pathological Complete Response Following Neoadjuvant Immunotherapy
Tianjin Medical University Cancer Institute and Hospital
Not yet recruiting
NCT07156604 2025-09-05
Vebreltinib for Neoadjuvant in METex 14 Skipping Mutant Stage IIA-IIIB (N2) Non-small Cell Lung Cancer (NSCLC)
Fudan University
Phase 2 Not yet recruiting
NCT07153770 2025-09-04
Bozitinib Combined With Chemotherapy as Radical Treatment for Stage IIA-IIIC MET-Altered Non-Small Cell Lung Cancer
Shanghai Pulmonary Hospital, Shanghai, China
Phase 2 Not yet recruiting
NCT07134413 2025-08-21
QL1706/Bevacizumab ± Chemotherapy in Post-ICI Non-Squamous NSCLC
Guangdong Association of Clinical Trials
Phase 2 Not yet recruiting
NCT07089199 2025-07-28
TitAN
Qilu Hospital of Shandong University
Phase 2 Not yet recruiting
NCT07086326 2025-07-25
NEOINSPIRE
Peking University People's Hospital
Phase 2 Not yet recruiting
NCT06944470 2025-04-25
JS207 Combined With Chemotherapy in Subjects With Stage II-III NSCLC
Shanghai Junshi Bioscience Co., Ltd.
Phase 2 Not yet recruiting
NCT06672068 2024-12-30
A Study of TY-9591 With Chemotherapy as 1st Line Treatment in Patients With Mutated Epidermal Growth Factor Receptor NSCLC
TYK Medicines, Inc
Phase 2 Not yet recruiting
NCT06739031 2024-12-18
Clinical Trial to Evaluate the Efficacy and Safety of Pulsed Electric Field Ablation Devices in the Treatment of Lung Tumors
Energenx Medical LTD.
Phase NA Not yet recruiting
NCT06735508 2024-12-16
MRNA Neoantigen Vaccine in Non-Small Cell Lung Cancer
Guangdong Provincial People's Hospital
Phase EARLY_PHASE1 Not yet recruiting
NCT06414915 2024-05-16
Surufatinib Combined With Tislelizumab in Advanced Lung Cancer With Neuroendocrine Differentiation
National Cancer Center, China
Phase 2 Not yet recruiting
NCT06329648 2024-03-26
DECIDE
The Netherlands Cancer Institute
Not yet recruiting
NCT06182761 2023-12-27
WUKONG-9
Shanghai Zhongshan Hospital
Phase 2 Not yet recruiting